Scripps starts pilot study of AirStrip mobile medical app

Scripps Health President Chris Van Gorder

Scripps Health has launched a pilot study of AirStrip One, a software system that delivers hospital patient-monitoring data to physicians' mobile devices. The 60-day pilot study, which is slated to end in early October, is intended to evaluate the potential for broader adoption.

In August, the physician-targeted app received $25 million from venture investors to continue the growth of AirStrip One, as well as to enable an expansion into home health and international efforts, as well as integration with an analytics engine.

"The AirStrip One pilot study fits with Scripps' broader effort to evaluate and adopt the most promising digital health technology that can help to improve patient outcomes and transform the way we deliver healthcare," said Scripps President and CEO Chris Van Gorder in a statement.

The startup touts AirStrip One as the "first complete, enterprise-wide clinical mobility solution." It integrates live patient data, including waveforms and vitals, in near real-time and also enables EMR and patient information such as labs and imaging, regardless of the original source. This allows healthcare providers to access patient information remotely via their mobile devices.

The system is already widely used, particularly in maternity wards, where it allows healthcare providers to closely monitor patients remotely during childbirth. One in 6 babies born in the U.S. is monitored with AirStrip and 1.2 million at-risk patients were monitored last year alone, according to the company.

At Scripps, the system is being used at its La Jolla, CA, hospital in the critical care unit that receives post-open heart surgery patients, trauma patients, surgical intensive care patients and others. Physicians aren't alone in using AirStrip to access patient data; nurse practitioners and physician assistants are also using the app.

No slouch when it comes to integrating innovation in patient care, Scripps Health has participated in pilot studies and clinical trials to evaluate wireless sensors to track blood pressure, blood sugar, brain activity, electrical heart rate and other key vital signs. Through the affiliated Scripps Translational Science Institute, which works in collaboration with The Scripps Research Institute, more than a dozen digital health studies are ongoing, supported by a $29 million award from the U.S. National Institutes of Health.

- here is the release on the Scripps pilot trial

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.